Amgen Drops Eczema Drug Pact As Investors Weigh R&D Focus And Valuation simplywall.st Source link
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus ts2.tech Source link
DUBLIN–(BUSINESS WIRE)–The “Hand Eczema (HE) – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This ‘Hand Eczema (HE)- Epidemiology Forecast – 2032’ report delivers an in-depth understanding of Hand Eczema (HE) historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Hand Eczema […]